Report Detail

Request for Sample of this report

Chemical & Material Global Vancomycin for Home Infusion Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4648679
    • |
  • 18 November, 2025
    • |
  • Global
    • |
  • 127 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Vancomycin for Home Infusion market size was valued at US$ 506 million in 2024 and is forecast to a readjusted size of USD 623 million by 2031 with a CAGR of 3.1% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Vancomycin for Home Infusionrefers to the administration of the antibiotic vancomycin in a home healthcare setting through intravenous (IV) infusion. Vancomycin is primarily used to treat serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Home infusion therapy allows patients to receive treatment outside the hospital, typically through a peripherally inserted central catheter (PICC) or other long-term IV access device. This approach improves patient comfort, reduces hospital stays, and lowers healthcare costs while maintaining clinical effectiveness, provided that proper monitoring of drug levels (trough concentrations), renal function, and infusion-related reactions is maintained.
This report is a detailed and comprehensive analysis for global Vancomycin for Home Infusion market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vancomycin for Home Infusion market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Vancomycin for Home Infusion market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Vancomycin for Home Infusion market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Vancomycin for Home Infusion market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vancomycin for Home Infusion
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vancomycin for Home Infusion market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Baxter, Cumberland, Viatris, Apotex, Hikma, Fresenius Kabi, Novartis, Sandoz, Xellia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vancomycin for Home Infusion market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
250 mg/vial
500 mg/vial
1 g/vial
2 g/vial
Market segment by Application
Skin & Soft Tissue Infections
Bone & Joint Infections
Cardiovascular Infections
Respiratory Infections
Other Infections
Major players covered
Pfizer
Baxter
Cumberland
Viatris
Apotex
Hikma
Fresenius Kabi
Novartis
Sandoz
Xellia
Orchid Pharma
Cipla
Sun Pharmaceutical
Aurobindo Pharma
Qilu Pharmaceutical
Haibin Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vancomycin for Home Infusion product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vancomycin for Home Infusion, with price, sales quantity, revenue, and global market share of Vancomycin for Home Infusion from 2020 to 2025.
Chapter 3, the Vancomycin for Home Infusion competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vancomycin for Home Infusion breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vancomycin for Home Infusion market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vancomycin for Home Infusion.
Chapter 14 and 15, to describe Vancomycin for Home Infusion sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Vancomycin for Home Infusion Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 250 mg/vial
    • 1.3.3 500 mg/vial
    • 1.3.4 1 g/vial
    • 1.3.5 2 g/vial
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Vancomycin for Home Infusion Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Skin & Soft Tissue Infections
    • 1.4.3 Bone & Joint Infections
    • 1.4.4 Cardiovascular Infections
    • 1.4.5 Respiratory Infections
    • 1.4.6 Other Infections
  • 1.5 Global Vancomycin for Home Infusion Market Size & Forecast
    • 1.5.1 Global Vancomycin for Home Infusion Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Vancomycin for Home Infusion Sales Quantity (2020-2031)
    • 1.5.3 Global Vancomycin for Home Infusion Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Vancomycin for Home Infusion Product and Services
    • 2.1.4 Pfizer Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Baxter
    • 2.2.1 Baxter Details
    • 2.2.2 Baxter Major Business
    • 2.2.3 Baxter Vancomycin for Home Infusion Product and Services
    • 2.2.4 Baxter Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Baxter Recent Developments/Updates
  • 2.3 Cumberland
    • 2.3.1 Cumberland Details
    • 2.3.2 Cumberland Major Business
    • 2.3.3 Cumberland Vancomycin for Home Infusion Product and Services
    • 2.3.4 Cumberland Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Cumberland Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Vancomycin for Home Infusion Product and Services
    • 2.4.4 Viatris Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 Apotex
    • 2.5.1 Apotex Details
    • 2.5.2 Apotex Major Business
    • 2.5.3 Apotex Vancomycin for Home Infusion Product and Services
    • 2.5.4 Apotex Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Apotex Recent Developments/Updates
  • 2.6 Hikma
    • 2.6.1 Hikma Details
    • 2.6.2 Hikma Major Business
    • 2.6.3 Hikma Vancomycin for Home Infusion Product and Services
    • 2.6.4 Hikma Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hikma Recent Developments/Updates
  • 2.7 Fresenius Kabi
    • 2.7.1 Fresenius Kabi Details
    • 2.7.2 Fresenius Kabi Major Business
    • 2.7.3 Fresenius Kabi Vancomycin for Home Infusion Product and Services
    • 2.7.4 Fresenius Kabi Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Fresenius Kabi Recent Developments/Updates
  • 2.8 Novartis
    • 2.8.1 Novartis Details
    • 2.8.2 Novartis Major Business
    • 2.8.3 Novartis Vancomycin for Home Infusion Product and Services
    • 2.8.4 Novartis Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Novartis Recent Developments/Updates
  • 2.9 Sandoz
    • 2.9.1 Sandoz Details
    • 2.9.2 Sandoz Major Business
    • 2.9.3 Sandoz Vancomycin for Home Infusion Product and Services
    • 2.9.4 Sandoz Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sandoz Recent Developments/Updates
  • 2.10 Xellia
    • 2.10.1 Xellia Details
    • 2.10.2 Xellia Major Business
    • 2.10.3 Xellia Vancomycin for Home Infusion Product and Services
    • 2.10.4 Xellia Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Xellia Recent Developments/Updates
  • 2.11 Orchid Pharma
    • 2.11.1 Orchid Pharma Details
    • 2.11.2 Orchid Pharma Major Business
    • 2.11.3 Orchid Pharma Vancomycin for Home Infusion Product and Services
    • 2.11.4 Orchid Pharma Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Orchid Pharma Recent Developments/Updates
  • 2.12 Cipla
    • 2.12.1 Cipla Details
    • 2.12.2 Cipla Major Business
    • 2.12.3 Cipla Vancomycin for Home Infusion Product and Services
    • 2.12.4 Cipla Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Cipla Recent Developments/Updates
  • 2.13 Sun Pharmaceutical
    • 2.13.1 Sun Pharmaceutical Details
    • 2.13.2 Sun Pharmaceutical Major Business
    • 2.13.3 Sun Pharmaceutical Vancomycin for Home Infusion Product and Services
    • 2.13.4 Sun Pharmaceutical Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.14 Aurobindo Pharma
    • 2.14.1 Aurobindo Pharma Details
    • 2.14.2 Aurobindo Pharma Major Business
    • 2.14.3 Aurobindo Pharma Vancomycin for Home Infusion Product and Services
    • 2.14.4 Aurobindo Pharma Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Aurobindo Pharma Recent Developments/Updates
  • 2.15 Qilu Pharmaceutical
    • 2.15.1 Qilu Pharmaceutical Details
    • 2.15.2 Qilu Pharmaceutical Major Business
    • 2.15.3 Qilu Pharmaceutical Vancomycin for Home Infusion Product and Services
    • 2.15.4 Qilu Pharmaceutical Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.16 Haibin Pharmaceutical
    • 2.16.1 Haibin Pharmaceutical Details
    • 2.16.2 Haibin Pharmaceutical Major Business
    • 2.16.3 Haibin Pharmaceutical Vancomycin for Home Infusion Product and Services
    • 2.16.4 Haibin Pharmaceutical Vancomycin for Home Infusion Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Haibin Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Vancomycin for Home Infusion by Manufacturer

  • 3.1 Global Vancomycin for Home Infusion Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Vancomycin for Home Infusion Revenue by Manufacturer (2020-2025)
  • 3.3 Global Vancomycin for Home Infusion Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Vancomycin for Home Infusion by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Vancomycin for Home Infusion Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Vancomycin for Home Infusion Manufacturer Market Share in 2024
  • 3.5 Vancomycin for Home Infusion Market: Overall Company Footprint Analysis
    • 3.5.1 Vancomycin for Home Infusion Market: Region Footprint
    • 3.5.2 Vancomycin for Home Infusion Market: Company Product Type Footprint
    • 3.5.3 Vancomycin for Home Infusion Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Vancomycin for Home Infusion Market Size by Region
    • 4.1.1 Global Vancomycin for Home Infusion Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Vancomycin for Home Infusion Consumption Value by Region (2020-2031)
    • 4.1.3 Global Vancomycin for Home Infusion Average Price by Region (2020-2031)
  • 4.2 North America Vancomycin for Home Infusion Consumption Value (2020-2031)
  • 4.3 Europe Vancomycin for Home Infusion Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Vancomycin for Home Infusion Consumption Value (2020-2031)
  • 4.5 South America Vancomycin for Home Infusion Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Vancomycin for Home Infusion Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Vancomycin for Home Infusion Sales Quantity by Type (2020-2031)
  • 5.2 Global Vancomycin for Home Infusion Consumption Value by Type (2020-2031)
  • 5.3 Global Vancomycin for Home Infusion Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Vancomycin for Home Infusion Sales Quantity by Application (2020-2031)
  • 6.2 Global Vancomycin for Home Infusion Consumption Value by Application (2020-2031)
  • 6.3 Global Vancomycin for Home Infusion Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Vancomycin for Home Infusion Sales Quantity by Type (2020-2031)
  • 7.2 North America Vancomycin for Home Infusion Sales Quantity by Application (2020-2031)
  • 7.3 North America Vancomycin for Home Infusion Market Size by Country
    • 7.3.1 North America Vancomycin for Home Infusion Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Vancomycin for Home Infusion Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Vancomycin for Home Infusion Sales Quantity by Type (2020-2031)
  • 8.2 Europe Vancomycin for Home Infusion Sales Quantity by Application (2020-2031)
  • 8.3 Europe Vancomycin for Home Infusion Market Size by Country
    • 8.3.1 Europe Vancomycin for Home Infusion Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Vancomycin for Home Infusion Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Vancomycin for Home Infusion Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Vancomycin for Home Infusion Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Vancomycin for Home Infusion Market Size by Region
    • 9.3.1 Asia-Pacific Vancomycin for Home Infusion Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Vancomycin for Home Infusion Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Vancomycin for Home Infusion Sales Quantity by Type (2020-2031)
  • 10.2 South America Vancomycin for Home Infusion Sales Quantity by Application (2020-2031)
  • 10.3 South America Vancomycin for Home Infusion Market Size by Country
    • 10.3.1 South America Vancomycin for Home Infusion Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Vancomycin for Home Infusion Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Vancomycin for Home Infusion Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Vancomycin for Home Infusion Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Vancomycin for Home Infusion Market Size by Country
    • 11.3.1 Middle East & Africa Vancomycin for Home Infusion Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Vancomycin for Home Infusion Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Vancomycin for Home Infusion Market Drivers
  • 12.2 Vancomycin for Home Infusion Market Restraints
  • 12.3 Vancomycin for Home Infusion Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Vancomycin for Home Infusion and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Vancomycin for Home Infusion
  • 13.3 Vancomycin for Home Infusion Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Vancomycin for Home Infusion Typical Distributors
  • 14.3 Vancomycin for Home Infusion Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Vancomycin for Home Infusion. Industry analysis & Market Report on Vancomycin for Home Infusion is a syndicated market report, published as Global Vancomycin for Home Infusion Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Vancomycin for Home Infusion market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo